Simulations Plus, Inc. (SLP) reported third-quarter fiscal 2025 adjusted earnings of 45 cents per share, which expanded 66.7% year over year. The figure also surpassed the Zacks Consensus Estimate of ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Azenta, Inc. made 41 cents a share (non-GAAP) on just over $656 million in revenue in FY2024. The current analyst firm ...

"The future has to be getting people to partner well and create together with the machines," Koller told Fortune.

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

Earnings season is kicking off with banks in the spotlight, but tech is stealing some limelight with Nvidia (likely) rebooting its chip sales to China (see below). Staying on China, our call of the ...

No administration has been immune to the impulse to investigate leaks. The reflex is bipartisan and familiar: An embarrassing disclosure appears in the press – contradicting official statements or ...

Understand the cash flow statement for Nautilus Biotechnology, Inc. (NAUT), learn where the money comes from and how the company spends it.

HAMILTON, BM / ACCESS Newswire / July 15, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing therapeutics that address important unmet med ...

IO Biotech Inc. Annual cash flow by MarketWatch. View IOBT net cash flow, operating cash flow, operating expenses and cash dividends.